Keywords: مسئولیت سوء استفاده; Nicotine; Abuse liability; Propylene glycol; Vegetable; glycerin; Wattage; Taste;
مقالات ISI مسئولیت سوء استفاده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مسئولیت سوء استفاده; Concentrated cannabis; Dabbing; THC; CBD; Marijuana; Abuse liability;
Keywords: مسئولیت سوء استفاده; Biologic; Biotherapeutic; Abuse liability; Drug abuse;
Keywords: مسئولیت سوء استفاده; Abuse liability; Drug discrimination; Receptor binding; Synthetic cannabinoids; Î;9-tetrahydrocannabinol; AM-1220; (R)-(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; AM-2232; 5-(3-(1-naphthoyl)-1H-indol-1-yl)pentanenitrile;
Keywords: مسئولیت سوء استفاده; Intravenous; Self-administration; Buprenorphine; Opioid; Abuse liability;
Keywords: مسئولیت سوء استفاده; Cannabinoids; Analgesia; Sex-differences; Abuse liability; Subjective effects;
Keywords: مسئولیت سوء استفاده; Lysergic acid diethylamide (LSD); Abuse liability; Hallucinogen; Reinforcing effects; Intravenous (IV) self-administration; Operant behavior;
Keywords: مسئولیت سوء استفاده; Dronabinol; Opioid withdrawal; Abuse liability; Treatment;
Keywords: مسئولیت سوء استفاده; Hydrocodone; Abuse liability; Abuse deterrents; Opioid analgesics; Acetaminophen; Pain; Pain management; Risk mitigation;
Keywords: مسئولیت سوء استفاده; Dimethylamylamine; Abuse liability; Conditioned place preference; Drug discrimination; Locomotor activity;
Keywords: مسئولیت سوء استفاده; Abuse deterrent; Tamper resistant; Pharmaceutical opioids; Opioids; Abuse liability; Cohort
Keywords: مسئولیت سوء استفاده; Drug safety; Drug control; Abuse liability; Biologics; Small molecule; Large molecule;
Keywords: مسئولیت سوء استفاده; Hydrocodone; Self administration; Drug discrimination; Drug dependence; Discontinuation syndrome; Withdrawal; Morphine; Oxycodone; Abuse liability; Methods;
Keywords: مسئولیت سوء استفاده; Cannabinoids; Abuse liability; Sex-differences; Subjective effects;
Keywords: مسئولیت سوء استفاده; Opioid substitution therapy; Methadone; Compliance; Abuse liability; Post-marketing surveillance;
Keywords: مسئولیت سوء استفاده; Intranasal; intravenous; self administration; buprenorphine; opioid; abuse liability
Keywords: مسئولیت سوء استفاده; Abuse liability; Qualification; Opioids; Placebo; Discrimination;
Keywords: مسئولیت سوء استفاده; Buprenorphine; Naloxone; Fatal poisoning; Drug abuse; Urine analysis; Abuse liability;
Keywords: مسئولیت سوء استفاده; Abuse deterrent; Abuse liability; Drug formulations; Opioid; Tamper resistant; Tampering;
Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
Keywords: مسئولیت سوء استفاده; Cannabidiol; CBD; Abuse liability; Smoked marijuana; Human;
The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users
Keywords: مسئولیت سوء استفاده; Opioid abuse; Glia; Oxycodone; Abuse liability; Opioids;
The effects of oral d-amphetamine on impulsivity in smoked and intranasal cocaine users
Keywords: مسئولیت سوء استفاده; Impulsivity; Amphetamine; Abuse liability; Cocaine users; Route;
Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model
Keywords: مسئولیت سوء استفاده; Abuse liability; Cannabinoids; Rats; Self-administration; Î9-Tetrahydrocannabinol; WIN55,212-2;
Gender and racial differences in smoking of long/ultra-long and king size cigarettes among U.S. adult smokers, NHANES 1999-2012
Keywords: مسئولیت سوء استفاده; Slim; Long; Design; Cigarettes; Abuse liability; Product appeal;
Cannabinoids in disguise: Δ9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles
Keywords: مسئولیت سوء استفاده; Abuse liability; Delta-9-tetrahydrocannabinol; Drug discrimination; Synthetic cannabinoids; UR-144; XLR-11
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations
Keywords: مسئولیت سوء استفاده; Abuse; Abuse liability; Clinical trial; Opioids; Prescription drug abuse; Risk of abuse; Study design;
Subjective and psychomotor effects of carisoprodol in combination with oxycodone in healthy volunteers
Keywords: مسئولیت سوء استفاده; Carisoprodol; Musculoskeletal relaxant; Prescription opioid; Oxycodone; Subjective effects; Abuse liability; Psychomotor performance; Healthy volunteer
Assessment of ropinirole as a reinforcer in rhesus monkeys
Keywords: مسئولیت سوء استفاده; Ropinirole; Cocaine; Monkey; Self-administration; Abuse liability
Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers
Keywords: مسئولیت سوء استفاده; Pregabalin; Opioid; Drug interaction; Subjective effects; Abuse liability; Healthy volunteer;
Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers
Keywords: مسئولیت سوء استفاده; Alprazolam; Benzodiazepine; Oxycodone; Prescription opioid; Subjective effects; Abuse liability; Psychomotor performance; Drug interaction; Healthy volunteer;
R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse
Keywords: مسئولیت سوء استفاده; Abuse liability; addiction; cocaine; dopamine transporter; methamphetamine; microdialysis
Effects of cold pressor pain on the abuse liability of intranasal oxycodone in male and female prescription opioid abusers
Keywords: مسئولیت سوء استفاده; Abuse liability; Prescription opioids; Pain; Gender;
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations
Keywords: مسئولیت سوء استفاده; Opioids; Opioid analgesics; Abuse; Abuse liability; Abuse potential;
Behavioural PharmacologyDiscriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem
Keywords: مسئولیت سوء استفاده; Drug discrimination; TPA-023; Alpha subunit; GABA; Benzodiazepine; (Rat); α; Abuse liability; Dependence;
Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers
Keywords: مسئولیت سوء استفاده; Carisoprodol; Musculoskeletal relaxant; Subjective effects; Abuse liability; Psychomotor performance; Healthy volunteer;
Conference on abuse liability and appeal of tobacco products: Conclusions and recommendations
Keywords: مسئولیت سوء استفاده; Tobacco; Nicotine; Abuse liability; Abuse potential; Addiction; Dependence; Formulation; Ingredients; Dose; Consumer; Product; Appeal; Marketing; Policy; Nicotine delivery;
Intravenous self-administration of gamma-hydroxybutyrate (GHB) in baboons
Keywords: مسئولیت سوء استفاده; Xyrem®; Gamma-hydroxybuturate (GHB); Cocaine; Self-administration; Operant behavior; Abuse liability
Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing
Keywords: مسئولیت سوء استفاده; Methadone; Buprenorphine; Buprenorphine-naloxone; Compliance; Supervised dosing; Diversion; Injection; Abuse liability;
Sigma Receptor Agonists: Receptor Binding and Effects on Mesolimbic Dopamine Neurotransmission Assessed by Microdialysis
Keywords: مسئولیت سوء استفاده; Abuse liability; addiction; cocaine; dopamine microdialysis; nucleus accumbens; reinforcing effects; sigma receptors
A possible link between sensation-seeking status and positive subjective effects of oxycodone in healthy volunteers
Keywords: مسئولیت سوء استفاده; Opioid; Oxycodone; Prescription opioid; Sensation-seeking; Personality; Subjective; Abuse liability; Human;
Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert Panel Report
Keywords: مسئولیت سوء استفاده; Prescription drug abuse; Regulation; Epidemiology; Policy; Pharmacovigilance; Abuse liability; Risk management; Surveillance
Risk management and post-marketing surveillance of CNS drugs
Keywords: مسئولیت سوء استفاده; Regulation; FDA; Risk management; REMS; Opioids; Controlled substance act; Abuse liability; Epidemiology; Pharmacovigilance; DEA
Markers of abuse liability of short- vs long-acting opioids in chronic pain patients: A randomized cross-over trial
Keywords: مسئولیت سوء استفاده; Prescription drug abuse; Long-acting opioids; Short-acting opioids; Abuse liability; Cue-reactivity
Principles of laboratory assessment of drug abuse liability and implications for clinical development
Keywords: مسئولیت سوء استفاده; Abuse liability; Clinical trial; Drug abuse; Drug development; Drug discrimination; Self-administration
Case histories in pharmaceutical risk management
Keywords: مسئولیت سوء استفاده; Abuse liability; Regulation; Post-marketing surveillance; Risk management; REMS; Medications; Opioids; Oxycodone; Buprenorphine; Amphetamine; Methylphenidate; Sodium oxybate; Lisdexamfetamine; Food and Drug Administration
A therapeutic dose of zolpidem has limited abuse-like effects in drug-naïve females: A pilot study
Keywords: مسئولیت سوء استفاده; Zolpidem; Benzodiazepine; Subjective effect; Abuse liability; Human volunteer
Abuse liability of intra-nasal midazolam in inhaled-cocaine abusers
Keywords: مسئولیت سوء استفاده; Benzodiazepines; Midazolam; Abuse liability
Novel discriminative stimulus effects of TPA023B, subtype-selective γ-aminobutyric-acidA/benzodiazepine modulator: Comparisons with zolpidem, lorazepam, and TPA023
Keywords: مسئولیت سوء استفاده; GABA; Subtype selectivity; Anxiolytic; Drug discrimination; Abuse liability; Benzodiazepine; Lorazepam; Zolpidem; TPA023; TPA023B; Training; Rat;
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers
Keywords: مسئولیت سوء استفاده; Hydrocodone; Oxycodone; Hydromorphone; Human; Opioid; Abuse liability; Analgesia; Prescription opioids
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations
Keywords: مسئولیت سوء استفاده; Abuse; Abuse deterrent formulation; Abuse liability; Opioids; Risk of abuse; Study design;